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Abstract X.arrestia is a recently identified retina-specific gene 
of unknown function. Affinity-purified anti-peptide antibody to 
human X-arrestin was prepared, and used in Western blot 
analysis of human retinal proteins and for immunohistoichemistry 
on human retinal sections. By Western blot analysis, the 
antibody specifically bound to an -47 kDa protein, and by 
indirect immunofluoresicenice specifiically labeled cone photore- 
ceptors with greatest intensity in their outer segments. In single 
and double label experiments, the loicalization of X-arrestin 
immunoreaictivity was compared with immunolabeling patterns 
obtained with antibodies to red/green cone opsin, rhodopsin, and 
S.antigen. The results showed that X-arrestin is expressed in 
red-, green, and blue-sensitive cones in the human retina. 
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I. Introduction 
Isolation and characterization of retina-specific genes have 
contributed greatly towards understanding of retinal biology 
and function, and pathogenesis of inherited retinal degenera- 
tions. Well-known examples of such genes include rhodopsin 
and peripherin [I,2]. Recently, S-antigen or retinal arrestin, 
which plays a role in desensitization of photoactivated rho- 
dopsin in phototransduction [3], joined the ranks of retinal 
genes that can cause retinopathy; a mutation in this gene 
was shown to be involved in Oguchi disease, a form of con- 
genital stationary night blindness [4]. 
In a project to isolate human retina-specific genes by a 
subtractive DNA cloning strategy, we isolated a eDNA en- 
coding a new type of retinal arrestin [5]. The eDNA encoded a
protein of 388 amino acid residues which showed a 49-58% 
homology to [I-arrestin and S.antigen, respectively, indicating 
its distinctness from the other arrestins. The gene was ex- 
pressed in photoreceptors, asassessed by in situ hybridization, 
and was named X-arrestin due to its X chromosome localiza- 
tion [5]. Another group subsequicntly isolated this gene, which 
they named C.arrestin, f'rom human, rat and Xenopus laevis 
[6,7] and predicted it to be cone-specific in expression on the 
basis of in situ hybridization in rat retina [6]. 
Precise cellular localization of the protein encoded by a 
newly isolated gene is an important step towards the goal of 
discovering its fi~nction, and is especially instructive in a com- 
partmentalized tissue such as retina, with its layered organiza- 
tion of highly differentiated classes of neurons. In this paper 
we report the preparation of an anti-peptide antibody directed 
against a unique sequence in X-arrestin, and its use in immu- 
nohistochemicai studies on human retinal sections, along with 
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antibodies to red/green cone opsin, rhodopsin and S-antigen 
to demonstrate the localization of X-arrestin in the three 
classes of human cone photoreceptors. 
2. Materials and methods 
2. !. Preparation of X.arrestin anti.peptide antibo@ 
The human X-arrestin sequence was analyzed for a unique region 
showing high antigcnicity by GenAlign ~md Piotstructure computer 
programs, respectively (GCG, Madison, WI). A 13 amino acid se- 
quence including an arbitrarily added cysteine (QKAVEAEODEGSC, 
residues 377-388) was chosen from the carboxy terminus, and the 
peptide was synthesized and used to prepare an anti-peptide antibody 
as described [8]. Briefly, 5 mg of peptide was coupled to keyhole 
limpet hemocyanin using m.maleimidobenzoic acid N-hydroxysuccini- 
mide ester (MBS), purified through Sephadex G-25, mixed with 
Freund's complete adjuvant, and used for immunization of a New 
Zealand white rabbit. Every 2-3 weeks thereafter, the rabbit was im- 
munized with a half dose of antigen in incomplete Freund's adjuvant, 
and serum was obtained. The antiserum, along with preimmune set- 
urn, was tested for antibody activity by Western blot analysis. All use 
of animals (rabbits and rats) was in accordance with the guidelines 
established in the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research. 
The antiserum was purified by affinity chromatography asdescribed 
[8]. Briefly, an affinity column was prepared by coupling bovine serum 
albumin to the synthetic peptide using MBS, purifying it through 
Sephadex G-25, then coupling it to CNBr.activated Sepahrose 4B 
(Pharmacia Biotech, Piscataway N J). The antiserum was passed 
through the affinity column, and the bound antibody was eluted 
with glycine after washing, lgG concentration was estimated by spec- 
trophotometry (OD2so). 
2.2. Western blot analysis 
Retinas were obtained from human Eye Bank eyes, homogenized in 
single-dctergent-lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCI, 
0.02% sodium azide, 100 pg/ml phenylmethylsulfonyi fluoride, 1 ~tg/mi 
aprotinin, I% Triton X-100), and centrifuged to prepare retinal ex- 
tract. Protein concentration was determined with Micro Protein De- 
termination (Sigma, St. Louis, MO). 10 pg of retinal extract was 
subjected to sodium dodecyl sulfate-pelyacrylamide gel electrophor- 
esis (SDS-PAGE), and electrobiotted onto an lmmobilon membrane 
(Millipore, Bedford, MA). The membrane was blocked with non-fat 
dry milk., reacted with the whole antiserum or afffinity-purified anti- 
body (50-1000× dilution, 0.2-2.0 ~tg/ml, respectively), washed and 
reacted with biotinylated goat anti-rabbit IgG antibod}. Bound anti- 
body was visualized by reaction with streptavidin-alkaline phospha- 
tase conjugate (Gibed BRL, Gaithersburg, MD), followed by washing 
and treatment with nitroblue tetrazolium chloride and 5.bromo-4- 
chloro-3-indolyl phosphate p-toluidine salt for color development. 
2.3. Immunohistochemistry 
Human Eye Bank eyes and pigmented (Long Evans) rat eyes were 
fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, and 
dissected portions of retina-lined eyecups were embedded in O.C T. 
compound (Miles, Inc., Elkhart, IN). Cross-sections of retina (6 ~tm 
thickness) were prepared on a cryostat and used for immunostaining. 
Sections were first post-fixed in 4% paraformaldehyde, washed in 
phosphate-buffered saline (PBS) and blocked with 10% goat serum 
in PBS, then incubated for ! h at room temperature with one of 
the following antibodies: (I) afffinity-purified rabbit anti-human X- 
arrestin peptide .mtibody (5 ~g/ml); (2) rabbit antibody generated 
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against a2;~-residue p ptide in the N.terminal extension ofhuman red 
am] ~ cone oosins [9,10], 1:100 dilution; (3) MAbAg-C6 anti- 
bovint S-antisen monoclonal ntibody [11], 1:100 dilution, or (4) 
G26¢ anti.bovine rhodopsin monoclonal ntibody [12], 1:10 dilution. 
Following washing, sections were incubated with FITC-labeled goat 
anti-rabbit IgG, FITC-GARG (50x dilution; Organon Tecknika, 
Durham, NC) for the X-arrestin and red/green cone opsin antibodies, 
and FITC-labeied goat anti-mouse IsG, FITC-GAMG (50x dilution; 
BRL, Gaithersburg, MD) for the rbodopsin and S-antigen monocle- 
hal antibodies. Slides were then washed and mounted inglycerol/PBS. 
For double immunofluorescent his ochemistry, human retinal sec- 
tions were first processed for X-arrestin immunoreactivity as described 
above, except with the use of rhodamine labeled goat anti-rabbit lgO 
(Rh-GARG) ($0x dilution; Boehringer, Indianapolis, IN) as the in- 
itial secondary antibody. Sections were then washed, post-fixed incold 
methanol for 10 m!,.~ (only for subsequent reaction with the red/green 
gone opsin antibody, as recommended by John C. Saari, Ph.D) and 
further eacted with the second specific antibody, i.e. either anti-hu- 
man red/green cone opsin or anti.bovine S-antigen antibody. Follow- 
ing the wash step, sections were finally reacted with the appropriate 
FITC-taglp=d secondary a.tibody, i,e, FITC-GARG (for opsin) or 
FITC-GAMG (for S-antisen). Control sections for the double stain- 
ing experiments were reacted with both secondary antibodies i.e. Rh- 
GARG and either FITC-GARG or FITC-GAMG. All slides were 
examined ina Zoiss Photomicroscope !11by phas~ contrast and fluo- 
regenoe microscopy using filter sets elective for t'hodamine and fluo- 
regein. 
3, Results 
in this study, a rabbit polyclonai antibody was prepared 
against a 13-amino acid peptide chosen from the carboxy- 
end of the human X-arrestin sequence. Sequence homology 
is extensive among all members of the arrestin family [5]; 
because the carboxy end was one of the few unicLue regions 
of X-arrestin, the peptide sequence was derived from this re- 
gion. By Western blot analysis of human retinal homogenates, 
the whole rabbit antiserum showed activity predominantly 
against a protein with an appar~,nt size of ~47 kDa (data 
not shown). The anti-peptide antibody was purified by affinity 
chromatography, and on Western blot analysis, the purified 
X-arrestin antibody recognized a single band of ~, 47 kDa in 
human retinal extracts. This band was not reactive with the 
preimmune ~erum or the flow-through fraction from the af- 
finity purifi~tion (Fig, 1). 
The affinity purified human X-arrestin anti-peptide anti- 
body was used for indtrect immunofiuorescent s aining of 
rat and human retinal sections. No detectable immunoreac- 
tion was seen in sections of rat retina using this antibody 
(data not shown). In sections from human retina, prepared 
from the far periphery, positive immunoreactivity was ob- 
~rved in widely spaced cells with the appearance of cones 
(Fig. 2a). A faint immunofiuorescence reaction was visible 
throughout the length of these cells, from the synaptic termini 
to the outer segments, but the signal was generally most in- 
tense over their short outer segments (arrows, Fig. 2d). When 
X-arrestin immunostaining was performed on human retinal 
sections prepared from the cone-rich perifoveal region, posi- 
tively stained cone-shaped cells, with intensely reactive outer 
segments were more abundant (Fig. 2b,e). Control sections, 
reacted with X-arrestin preimmune serum revealed no specific 
staining of any retinal cell type (Fig. 2c). 
For comparison with the staining pattern seen with the X- 
arrestin antibody, adjacent sections from the same human 
retina were reacted with an antibody specifically recognizing 
opsin in red-and green-sensitive cone photoreceptors [9,10]. 
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Fig. I. Western blot analysis of human retinal homogenate proteins. 
Human retinal extracts were electrophoresed in 10% SDS-PAGE, 
transferred to a nylon filter and reacted with preintmune s rum 
from the rabbit used for antibody production (lane I), pass-through 
fraction from the affinity purification (lane 2), and affinity-purified, 
human X-arrestin anti-peptide antibody (lane 3). Bound antibody 
was visualized by the alkaline phosphatase color reaction. The X-ar- 
restin anti.peptide antibody recognizes a protein in human retina of 
-.47 kDa (arrow). The size markers are bovine serum albumin (66 
kDa), ovalbumin (45 kDa), and carbonic anhydrase (31 kDa). 
The results revealed a very similar pattern of immunostaining 
with either antibody (cf. Fig. 2e,f). Thus, the distribution of 
X-arrestin positive cells appeared to correspond closely to that 
of the red and green cones. By contrast, staining of adjacent 
sections with antibodies to rod-expressed proteins i.e. rhodop- 
sin and S-antigen, revealed strikingly different labeling pat- 
terns. With the A9C6 monocZoJ~al antibody against S-antigen, 
the entire rod photoreceptor layer was reactive, as previously 
described [I I], and the positions of the nuclei and inner seg- 
ments of the unstained cone cells were strikingly revealed as 
keyhole-shaped negatively stained areas between the strongly 
immunoreactive rod photoreceptors (arrows, Fig. 2g). As pre- 
viously shown [12], the G26c anti-rhodopsin antibody specifi- 
cally labeL, d just the outer segments of the rods, which ap- 
peared much longer and thinner than the outer segr~ents of 
the cones (compare Fig. 2e,f with Fig. 2h,i). 
In order to confirm the localization of X-arrestin in red and 
green cones, a double label procedure was performed using 
the antibodies against X-arrestin and red/green cone opsins on 
the same section (Fig. 3a,b). The result, visualized using filter 
sets selective for either hodamine or fluorescein, revealed that 
each cone cell positive for the red/green cone opsin was also 
positive for X-arrestin, thus confirming expression of X-ar- 
restin in red.and green-sensitive cone photoreceptors (Fig. 
3a,b). Very minimal background staining was seen in control 
sections doubly reacted with only the two fluorescent second- 
ary antibodies (Fig. 3c,d). 
To compare the distribution of the two classes of retinal 
arrestins, double labeling was performed using the X-arrestin 
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Fig. 2. Localization of X-arrestin in human retina by indirect immunofluorescence. Frozen sections of peripheral (a) and perifoveal (b) retina 
from two human donor eyes reacted with aflinity-purifie~ human X-arrestin anti-peptide antibody (a,b) or rabbit preimmune s rum (c). The 
wavy horizontal line seen at low power in (a-c) is due t J autofluorescence of lipofuschin i  the aged retinal pigment epithelium. Images in (d,e) 
are higher magnifications of sections shown in (a,b), respectively. Arrows in (d,e) point o cone outer segments. There is a slight detachment of 
the retina in most areas of the perifoveal sections. Adjacent perifoveal sections (f-h) show immunostaining patterns with anti-human red/green 
cone opsin antibody (f), anti-bovine S-antigen antibody (g), and anti-bovine rhodopsin antibody (h). The phase contrast image of the field in 
(h) is shown in (i). ONL, outer nuclear layer; OLM, outer limiting membrane; COS, cone outer segment; ROS, rod outer segment; RPE, ret- 
inal pigment epithelium. Magnification (a-c) ×60; (d-i) × 150. Bar= 165 pm in (a-c) and 65 gm in (d-i). 
and S-antigen antibodies. As predicted, the two immunofluo- 
rescent staining patterns obtained with this combination of 
antibodies were very different, with the X-arrestin antibody 
labeling the cones, and the S-Ag antibody labeling the rods in 
the same section (Fig. 3e-g). This experiment also document- 
ed that there was no overlap of the fluorescent signal emitted 
by the rhodamine-labeled cvnes when viewed through the 
fluorescein filter set, and similarly that the fluorescein-labeled 
rods could not be visualized with the rhodamine filter set (Fig. 
3e,f). This control verified that the precise co-localization of 
X.arrestin and red/green cone opsin in same cone ceils in the 
above double label experiment (Fig. 3a,b) was due to signal 
uniquely emitted by one or the otlicr fluorescently tagged 
secondary antibody, with no overlap of emission spectra visi- 
ble with filter sets used. 
The experiments described above clearly indicated expres- 
sion of X-arrestin in red-and green-sensitive cones and not 
rods. The human retina also contains blue-sensitive cones, 
which are relatively scarce compared with the red/green cones 
[13,14]. The A9C6 S-antigen anti-peptide antibody used in this 
study has been conclusively shown to recognize not only the 
rods, but also the blue cones [15,16]. We took advantage of 
this characteristic of the antibody to investigate whether X- 
arrestin is expressed in blue cone~. To do so, sections double 
immunolabeled with the X-arrestin and the A9C6 antibodies 
were carefully examined at high power to look for es,idence of 
cones that were double labeled with X-arrestin and A9C6. 
Indeed, while the great majority of the cones was not labeled 
by A9C6, a few double labeled cones could be found, three 
examples of which are shown in Fig. 4. These cells were there- 
fore blue cones that were expressing X-arrestin. Conversely, 
since the: anti-peptide antibody recognizing a sequence in red 
and green cone opsin specifically labels red and green cones 
[9,10], it would be expected from the double label experiment 
with the X-arrestin and red/green cone opsin antibodies that a 
small percentage of the cones, representing the blue cones, 
would be positive for X-arrestin but negative for red/green 
cot~,~- opsin. This was also found to be the case, as shown in 
Fig. 5, which is from an adjacent section of the same retina 
shown in Fig. 4. This data thus provided further indirect 
evidence for the expression of X-arrestin in blue cones. 
4. Discussion 
Our initial attempt to localize X-arrestin within the retina 
by in situ hybridization gave equivocal results [5]. Despite 
repeated attempts using a carefully chosen aSS-labeled ribo- 
probe specific for X-arrestin, silver grains were heavily distrib- 
uted over inner segments of both rods and cones in sections of 
human retina following liquid emulsion autoradiography. 
Using this technique and this particular probe, we could 
only conclude that X, arrestin is expressed predominantly in
photoreceptors in the hl~man retina. CraR et al. [6] also used 
in situ hybridization to localize the expression of X.arrestin 
(named C-arrestin by them), and although the precise se- 
quence of their riboprobe was not described, they reported 
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Fig. 3. Double immunofiuorescent localization of X'arrestin in human retina. (a,b) Double immunolabel with X-arrestin and red-green cone op- 
sin antibodies. A section of perifoveal human retina was sequentially reacted with rabbit anti-X,arrestin antibody, Rh-GARG, rabbit anti-red/ 
green cone opsin antibody and FITC-GARG. Note the precise corres2Jon,~ence of positively stained cones, doubly labeled with the X-arrestin 
antibody (viewed with the Rh filter set in a) and with the red/green cone opsin an~:ibody (viewed through the FITC filter set in b). (c,d) Adja- 
cent control section from retina shown in (a,b) doubly reacted with Rh-GARG (c) and FITC-GARG (d) alone, viewed with corresponding fil- 
ter sets. (e,f) Double immunolabel with X-arrestin and S-antigen antibodies. Specific localization of X-arrestin to Rh-tagged cones is seen in 
(e), whereas S-Ag distribution is confined to the FITC-ta88ed rods in the section, si~own in (f). (8) Phase contrast image of the section shown 
in (e,f), Magnification (a,b,e-g) ×230; (c,d) × 150, Bar= 165 pm in (c,d) and 43 pm in (a,b,e--g). 
Fig. 4. Localization of X-arrestin in blue cones. High magnilitmtion micmgraphs of the section shown in Fig. 3e-g, double stained with X-ar- 
restin (a,d,f) and A9C6 S-Ag (b,e,g) antibodies. The panels how three examples of X-arrestin positive cones (arrows) showing immunoreactiv- 
ity with A9C6, thereby identifying them as blue cones. Adjacent X-arrestin positive cone cells, negative for A9C6 (asterisks) are red/green 
cones. Magnification, all panels x375. Bar-27 pun. 
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Fig. 5. Same section shown in Fig. 3a,b, showing double immunostaitling of' human, retina with X-arrestin (a,d,f) and red/green cone opsin 
(b,e,g) antipeptide antibodies. Image in (c) is the phase contrast image of th,~ section shown in (a,b). Arrows indicate three xamples of X-ar- 
restin positive cones that are negative for red/green cone opsin, and a~'e therefore assumed to be blue cones. Magnification, all figures × 375. 
Bar- 27 ~tm. 
that the probe was sufficiently specific to demonstrate cone- 
specific expression in rat retina. The rat is a challenging ex- 
perimental model for study of cones, however, because cones 
are very scarce in the rat retina and closely resemble the rods 
in shape. By light microscopy of I ~tm thick plastic sections of 
mouse and rat retina fixed for electron microscopy with glu- 
taraldehyde and paraformaidehyde, cones can be distin- 
quished from rods primarily by their nuclear morphology, 
and location of the nuclei predominantly in the outer on¢ 
third to one half of the outer nuclear layer (ONL), often close 
to the outer limiting membrane [17,18]. However, in situ hy- 
bridization is typically carried out using 6-8 tam frozen or 
paraffin sections of retina immersion fixed only with parafor- 
maldehyde; under these conditions morphological preserva- 
tion is quite poor and subtleties of nuclear morphology are 
lost (e.g. see Fig. 5a of our previous study [5] and Fig. 5 of 
[6]). Additionally, the resolution of this technique is limited by 
scatter of the signal, inherent in use of aSS-labeled riboprobes 
and liquid emulsion autoradiography. Previous evidence in 
support of C.arrestin expression in cones [6] has been limited 
to demonstration i  rat retina of very sparse label associated 
with a small percentage of the nuclei in the ONL, mainly 
located near the outer limiting membrane. Surprisingly, no 
silver grains were seen over the inner segments, the site of 
translation. The localization of C-arrestin was postulated to 
be in cones, based on the number and position of the labeled 
nuclei seen by in situ hybridization [6], but as discussed above, 
without definitive identification of the cone nuclei, it is not 
clear how it could be concluded that the signal was originating 
from cones. 
In marked contrast to the technique of in situ hybridization, 
which at best enables the localization of expression of an 
mRNA to a particular cell type in the retina, immunohisto- 
chemistry allows for precise subcellular localization of the 
protein at the light microscopic level, as shown in this study. 
Anti-peptide antibodies, specifically designed to recognize 
unique antigenic determinants within proteins, are especially 
powerful tools that can enable ven closely related proteins to 
be distinguished and localized by i~munohhtochemisty. The
affinity purified anti-peptide antibody/prepared in this study 
against a unique 13 amino acid sequence in the carboxy ter- 
minus of human X-arrestin showed specific activity against a 
single band of ~47 kDa on Western blots of human retinal 
homogenate. When used for immunolocalization i human 
retina along with antibodies recognizing other cone-and rod- 
specific proteins, this antibody conclusively demonstrated X-
arrestin to be expressed in cone photoreceptors. The pattern 
of immunolabeling of cones in sections doubly reacted with 
the X-arrestin and red/green cone opsin antibodies clearly in- 
dicated that X-arrestin is expressed in the red-and green-sen- 
sitive cones. The data from the double label experiments with 
the two combinations of antibodies, i.e. X-arrestin + A9C6 
and X-arrestin + iedlgree~ cone opsin confirmed the localiza- 
tion of X.arrestin in blue-sensitive cones. Thus it can be con- 
cluded that X.arrestin is expressed in all three classes of cones 
in the human retina. The predominant localization to the out- 
er segments of these cells is consistent with a putative role for 
X-arrestin in cone phototransduction. The fainter eaction of 
the X-arrestin antibody in other parts of the cone photorecep- 
tors, e.g. the synaptic termini, could be an artifact resulting 
from postmortem diffusion of the molecules. Alternatwely, 
this result may reflect bona fide presence of X-arrestin or a 
similar molecule in other comFartments of the cell, as sug- 
gested for S-antigen in rod photoreceptors [19]. Further stu- 
dies using experimental nimals with retinas amenable to 
study of cones will be needed to pursue this question. 
Arrestins are thought o work by competing with the rele- 
vant G-protein for interaction with the receptor in a signal 
transduction cascade [3]. The carboxy terminal region has 
been shown to be unique and functionally important for 
each type of arrestin [20]. The carboxy-terminal region of 
X.arrestin is quite different from that of the other retinal 
arrestin, i.e., S.antigen, and in fact, is slightly more similar 
to 13-arrestin [5]. Thus, it is interesting that the present data 
suggests on the basis of predominant localization in the cone 
outer segments hat X-arrestin might interact with cone opsins 
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to effect heir desensitization. I  that case, X-arrestin might be 
expected to share more homology with S-antigen, which inter- 
acts with the rod visual pigment, rhodopsin. On the other 
hand, the dissimilarity may indicate that cone phototransduc- 
tion involves a pathway different from that of rods. As de- 
monstrated here for X-arrestin, use of an antibody prepared 
against he ot subunit of cone transducin has provided evi- 
dence for expression of the same transducin subunit in all 
three types of human cones [9]. Expression of recombinant 
X-arrestin for use in functional studies may clarify the specific 
pathway in which this new arrestin participates. 
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